Results 1 to 10 of about 6,904 (161)
Factors associated with the circulation of vaccine-derived polioviruses in children under five in Kilwa, Haut-Katanga province, Democratic Republic of Congo, 2022–2023 [PDF]
BMC Infectious DiseasesIntroduction Since the World Health Organization declared the African region free of wild poliovirus in August 2020, vaccine-derived polioviruses (VDPV) have remained the only form of poliovirus still circulating on the continent, including in the ...
Jean Blaise Yobo Iyala +7 more
doaj +2 more sources
Enhanced Inactivated Poliovirus Vaccine [PDF]
Canadian Journal of Infectious Diseases, 1994 Ronald Gold
doaj +3 more sources
Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment [PDF]
Frontiers in Public HealthPoliomyelitis has been a significant global health challenge for centuries. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, remarkable progress has been achieved, with wild poliovirus (WPV) cases reduced by over 99%.
Jia Liang, Qi Zhang, Yanan Li, Lili Wang
doaj +2 more sources
Long-Term Persistence of Anti-Poliovirus Antibody Titers After Two-Dose Booster Immunization with Conventional Inactivated Poliovirus Vaccine Among Japanese Adults: 10-Year Observational Study [PDF]
VaccinesBackground/Objectives: Most Japanese adults received two doses of the oral polio vaccine (OPV) during childhood as part of the national immunization program. However, these two doses are considered suboptimal by global standards.
Shinji Fukushima +4 more
doaj +2 more sources
Western Pacific Surveillance and Response, 2022 Objective: In response to an outbreak of circulating vaccine-derived poliovirus (cVDPV) type 2 in the Philippines in 2019–2020, several rounds of supplementary immunization activities using the monovalent type 2 oral poliovirus vaccine (OPV) were ...
SweetC B Alipon +12 more
doaj +1 more source
Poliomyelitis amidst the COVID-19 pandemic in Africa: Efforts, challenges and recommendations
Clinical Epidemiology and Global Health, 2022 Poliomyelitis is the leading infectious cause of acute flaccid paralysis among children under five years of age, caused by the Wild Poliovirus, with no medical cure other than prevention through vaccination.
Olivier Uwishema +7 more
doaj +1 more source
Revista Paulista de Pediatria, 2021 Objective: To describe the prevalence of neutralizing antibodies against poliovirus (PV1, PV2, and PV3) in blood samples of healthcare professionals aged 20 to 50 years.
José Cassio de Moraes +2 more
doaj +2 more sources
Vaccines, 2022 Oral and inactivated poliovirus (PV) vaccines have contributed toward the global eradication of wild PV2 and PV3, as well as the elimination of PV1 in most countries.
Angela Maria Vittoria Larocca +5 more
doaj +1 more source
Vaccines, 2020 The enhanced inactivated poliovirus vaccine was first introduced in 2002, and several inactivated poliovirus vaccines are licensed in Korea. Reliable data by a prospective study on the immunogenicity and safety of the inactivated poliovirus vaccines in ...
Byung Ok Kwak +8 more
doaj +1 more source
The Pathology of Poliomyelitis and the Vaccines and Nonvaccine Therapy [PDF]
E3S Web of Conferences, 2021 Poliomyelitis is an exclusively human disease that mainly affects children. Clinical features of poliomyelitis can be varied, from mild illness to the most severe paralysis, and the factor why poliomyelitis has different performances in individuals has ...
Chen Yushuo, Yue Tianrui, Zhang Zixiao
doaj +1 more source